| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 6.929 | 25.130 | 28.018 | 29.326 | 53.579 | 79.963 | 76.656 | 44.793 | 62.717 |
| Total Income - EUR | - | 6.929 | 25.131 | 28.018 | 29.416 | 53.580 | 79.963 | 76.657 | 44.794 | 62.718 |
| Total Expenses - EUR | - | 6.631 | 18.241 | 15.587 | 29.156 | 29.013 | 33.321 | 36.409 | 31.001 | 54.061 |
| Gross Profit/Loss - EUR | - | 298 | 6.890 | 12.431 | 260 | 24.567 | 46.642 | 40.248 | 13.793 | 8.657 |
| Net Profit/Loss - EUR | - | 162 | 6.638 | 12.151 | -34 | 24.309 | 46.120 | 39.634 | 13.345 | 6.813 |
| Employees | - | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 |
Check the financial reports for the company - Dr. Alergolog-Imunolog Urdea Delia S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 18 | 0 | 0 | 21.265 | 16.188 | 12.774 | 8.848 | 3.961 | 2.684 |
| Current Assets | - | 4.275 | 7.428 | 17.327 | 16.440 | 30.013 | 68.837 | 32.055 | 23.928 | 39.486 |
| Inventories | - | 2.616 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 52 | 2.186 | 2.254 | 15.173 | 28.723 | 67.550 | 31.768 | 23.456 | 35.451 |
| Cash | - | 1.607 | 5.242 | 15.073 | 1.267 | 1.290 | 1.287 | 287 | 471 | 4.035 |
| Shareholders Funds | - | 206 | 6.841 | 16.604 | 16.249 | 34.874 | 80.220 | 39.683 | 26.626 | 33.290 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 4.087 | 648 | 723 | 21.456 | 11.355 | 1.392 | 1.418 | 1.385 | 8.880 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. Alergolog-Imunolog Urdea Delia S.r.l.